Paid Clinical Trials in Maine
Here are the 6 most popular medical studies in Paid Studies Maine
Anti-metabolites
Intravesical BCG vs GEMDOCE for Bladder Cancer
Recruiting2 awardsPhase 3
Boston, Massachusetts
This trial tests if a new treatment, Gemcitabine + Docetaxel, is better or worse than the usual BCG therapy for bladder cancer. Primary goal is to measure event free survival, secondary objectives include changes in cancer-specific QOL, cystectomy free survival, progression free survival, and safety/toxicity.
Ventricular Restoration System
Ventricular Restoration System for Heart Failure
Recruiting1 award9 criteria
Bangor, Maine
This trial is testing a new device to help people with heart failure. The device is placed around the heart to help it pump better. The trial will test how well the device works and if it is safe.
Monoclonal Antibodies
Antibody + Chemoradiation for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Wilmington, Delaware
This trial is testing whether adding durvalumab to standard chemoradiation followed by additional durvalumab can extend patients life and/or prevent the tumor from coming back compared to the usual approach of chemoradiation alone followed by durvalumab.
Popular filter options for Paid Studies Maine trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Checkpoint Inhibitor
Immunotherapy with Nivolumab and Ipilimumab followed by Nivolumab or Nivolumab with Cabozantinib for Kidney Cancer
Recruiting2 awardsPhase 3
Stamford, Connecticut
This trial is testing a new combination treatment for patients with untreated renal cell carcinoma. The usual treatment is immunotherapy with ipilimumab and nivolumab, followed by nivolumab alone. The new treatment adds cabozantinib to nivolumab after initial treatment with ipilimumab and nivolumab. It is not yet known if this new combination treatment is better than the usual treatment.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Combination Therapy for Breast Cancer
Recruiting1 awardPhase 2
Hartford, Connecticut
This trial is studying how well paclitaxel, trastuzumab, and pertuzumab work in eliminating chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery.
Checkpoint Inhibitor
Immunotherapy with Nivolumab and Ipilimumab followed by Nivolumab or Nivolumab with Cabozantinib for Kidney Cancer
Recruiting2 awardsPhase 3
Stamford, Connecticut
This trial is testing a new combination treatment for patients with untreated renal cell carcinoma. The usual treatment is immunotherapy with ipilimumab and nivolumab, followed by nivolumab alone. The new treatment adds cabozantinib to nivolumab after initial treatment with ipilimumab and nivolumab. It is not yet known if this new combination treatment is better than the usual treatment.
View More Paid Studies Maine Trials
See another 84 many medical studies focused on Paid Studies Maine.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.